Download PDF
1 / Pages

Other users also viewed these articles

Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis Luis Vega; Daniela Simian; Abraham I. Gajardo; Marcelo Salinas; Andrea Urra; Máximo Cattaneo; Rosario Pino; Juan P. Roblero; Álvaro Urzúa; Katherine Rojas; Jaime Poniachik;
10.1016/j.aohep.2024.101511
Metabolic dysfunction: The silenced connection with fatty liver disease Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;
Ann Hepatol. 2023;28:
Non-invasive methods for iron overload evaluation in dysmetabolic patients Paula Pessin Fábrega Branisso; Claudia Pinto Marques Souza de Oliveira; Hilton Muniz Leão Filho; Fabiana Roberto Lima; Aritânia Sousa Santos; Marcio Correa Mancini; Maria Edna de Melo; Flair José Carrilho; Manoel de Souza Rocha; Paul Clark; Henrique José Pereira Branisso; Cintia Cercato;
10.1016/j.aohep.2022.100707